Sulfacytine
Sulfacytine is a sulfonamide antibiotic used in the treatment of various bacterial infections. It is a synthetic derivative of para-aminobenzoic acid (PABA) and works by inhibiting the synthesis of folic acid in bacteria, thereby preventing their growth.
History
Sulfacytine was first synthesized in the 1930s, following the discovery of the antibacterial properties of Prontosil, the first sulfonamide antibiotic. It was one of many sulfonamides developed in an attempt to create a broad-spectrum antibiotic with fewer side effects.
Mechanism of Action
Sulfacytine, like other sulfonamides, is a competitive inhibitor of dihydropteroate synthase (DHPS), an enzyme involved in the synthesis of folic acid in bacteria. By mimicking the structure of PABA, a substrate of DHPS, sulfacytine is able to bind to the enzyme and prevent it from catalyzing the conversion of PABA to dihydropteroate, a precursor of folic acid. This inhibits the growth of bacteria by depriving them of the folic acid necessary for DNA synthesis.
Clinical Use
Sulfacytine is used in the treatment of a variety of bacterial infections, including urinary tract infections, respiratory tract infections, and skin infections. It is also used in combination with other antibiotics in the treatment of tuberculosis.
Side Effects
Common side effects of sulfacytine include nausea, vomiting, and diarrhea. In rare cases, it can cause serious side effects such as Stevens-Johnson syndrome, a severe skin reaction, and hemolytic anemia, a condition in which red blood cells are destroyed faster than they can be made.
Resistance
Resistance to sulfacytine and other sulfonamides has become increasingly common among many types of bacteria. This is often due to mutations in the gene encoding DHPS, which can alter the enzyme's structure and prevent sulfacytine from binding to it.
| This article is a stub. You can help WikiMD by registering to expand it. |
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
